Robert E. Waltermire, Senior VP, Chief Pharma Development at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 1,900 shares at $280.00 ($532K) on 2024-06-14, disclosed to the SEC on 2024-06-18.
Open-market sale of $532k MDGL by Senior VP, Chief Pharma Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MDGL | SELL | 2025-01-27 | $35K | — | Filing → |
| MDGL | SELL | 2025-01-17 | $242K | — | Filing → |
| MDGL | SELL | 2024-06-14 | $570K | — | Filing → |